Paroxysmal atrial fibrillation
MONDO:1030011An atrial fibrillation disorder characterized by intermittent atrial fibrillation that lasts less than seven days from onset.
Also known as: paroxymsal AFib, paroxysmal AF
167 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Simple IV fluids may shield kidneys during new heart ablation technique
Disease control OngoingThis study tests whether giving extra fluids (saline) through an IV during and after a heart procedure called pulsed field ablation can prevent acute kidney injury. The procedure is used to treat atrial fibrillation, a common heart rhythm problem, but can sometimes harm the kidne…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a smartphone alert replace daily blood thinners for AF?
Disease control OngoingThis study tests a new approach called 'pill-in-pocket' anticoagulation for people with atrial fibrillation (AF), a heart rhythm condition that raises stroke risk. Instead of taking blood thinners every day, participants would stop them after a 30-day AF-free period and only rest…
Phase: NA • Sponsor: Oxford University Hospitals NHS Trust • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
More zaps, better rhythm? trial tests extra ablations for AFib
Disease control OngoingThis trial compares standard versus extra pulsed field ablation applications during pulmonary vein isolation in people with atrial fibrillation. The goal is to see if more targeted ablations improve freedom from irregular heart rhythms for up to 18 months. Participants are adults…
Phase: NA • Sponsor: R&D Cardiologie • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a bigger balloon tame the Heart's electrical chaos?
Disease control OngoingThis trial tests whether using a larger, expandable balloon during cryoablation for paroxysmal atrial fibrillation better affects the heart's autonomic (automatic) control compared to a standard-size balloon. About 40% of patients show signs of beneficial parasympathetic denervat…
Phase: NA • Sponsor: Wroclaw Medical University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New pulsed field ablation device aims to tame stubborn heart rhythm disorder
Disease control OngoingThis study tests a new device that uses pulsed electric fields to treat persistent atrial fibrillation, a type of irregular heartbeat. Researchers will enroll 200 people to see if the procedure is safe and can restore normal heart rhythm. The goal is to offer a more precise and l…
Phase: NA • Sponsor: CardioFocus • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New heart lead under watch: 5-Year safety check begins
Disease control ENROLLING_BY_INVITATIONThis study follows 2000 people who have or will get the OmniaSecure defibrillation lead, a wire that helps control dangerous heart rhythms. Researchers will track how often the lead causes problems over 5 years. The goal is to make sure the lead is safe and works as expected in e…
Sponsor: Medtronic • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Kidney ultrasound may help keep heart rhythm steady after second AFib procedure
Disease control OngoingThis study tests whether adding a kidney nerve treatment (renal denervation) to a repeat catheter ablation for atrial fibrillation (AFib) can lower the chance of AFib coming back. About 250 people with high blood pressure and AFib who need a second ablation will be randomly assig…
Phase: NA • Sponsor: Vivek Reddy • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New heart procedure tested for AFib control
Disease control OngoingThis study looks at how safe and effective a new treatment called FARAPULSE pulsed field ablation is for people with a type of irregular heartbeat called paroxysmal atrial fibrillation. About 228 participants will be followed for up to 12 months to see if the procedure stops the …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New catheter combo aims to keep AFib in check longer
Disease control OngoingThis study looks at how well a special catheter (THERMOCOOL SMARTTOUCH SF) and software (Ablation Index) work to treat paroxysmal atrial fibrillation, a type of irregular heartbeat. Researchers will track 150 adults who get this procedure to see if they stay free of heart rhythm …
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New antibiotic pouch aims to stop infections in heart device patients
Disease control OngoingThis study is tracking 100 adults who receive an EluPro antibiotic-eluting envelope during implantation of a heart device (like a pacemaker). The envelope slowly releases antibiotics to prevent infection. Researchers are monitoring complication rates in real-world use to see how …
Sponsor: Elutia Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Zap away heart flutters: new device trial offers hope for AF patients
Disease control OngoingThis study tests a new device that uses special electrical pulses to treat paroxysmal atrial fibrillation, a condition where the heart beats irregularly. About 150 adults aged 18-75 who have not responded well to medication will receive the treatment. The goal is to see if the de…
Phase: NA • Sponsor: Shanghai Shangyang Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New heart procedure could tame irregular heartbeat
Disease control OngoingThis study tests a new device system that uses pulsed electric fields to treat atrial fibrillation, a common heart rhythm problem. About 300 people with symptomatic, recurrent atrial fibrillation will receive the procedure. The goal is to see if it safely and effectively restores…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New ablation strategy aims to keep hearts in rhythm longer
Disease control OngoingThis study compares two catheter ablation techniques for atrial fibrillation (AF), a condition where the heart beats irregularly. One method uses a standard approach with a drug called adenosine to find missed spots, while the other adds an extra ring of ablation without the drug…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New heart procedure aims to stop persistent AFib in its tracks
Disease control OngoingThis study looks at two ways to treat a type of irregular heartbeat called non-paroxysmal atrial fibrillation (AFib) that doesn't go away on its own. Both methods use a new technique called pulsed-field ablation to destroy tiny areas of heart tissue causing the problem. One group…
Phase: NA • Sponsor: Xu Liu • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New heart procedure aims to zap AFib safely
Disease control OngoingThis study tests a device called the Farapulse system, which uses electrical pulses to treat atrial fibrillation (AFib), a common heart rhythm problem. Researchers will enroll 275 adults with AFib who are already scheduled for a catheter ablation procedure. The goal is to see if …
Phase: PHASE4 • Sponsor: Vivek Reddy • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New heart procedure could be safer and just as effective for AFib
Disease control OngoingThis study compares two ways to treat a heart condition called atrial fibrillation (AFib) that causes an irregular heartbeat. The standard method uses freezing (cryoballoon), while the newer method uses electrical pulses (pulsed field ablation). The goal is to see if the new meth…
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Blood test may help Fine-Tune heart drug dosing
Disease control ENROLLING_BY_INVITATIONThis study tests whether measuring amiodarone levels in the blood helps doctors choose the right dose for people with paroxysmal atrial fibrillation (a type of irregular heartbeat). About 80 adults will receive different daily doses (100, 200, or 400 mg) and be monitored for thre…
Phase: PHASE4 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New heart device aims to zap away irregular rhythm
Disease control OngoingThis study tests a new device called the Globe Pulsed Field System to treat people with atrial fibrillation (AF), a common heart rhythm problem. The device uses electrical pulses to destroy small areas of heart tissue causing the irregular rhythm. About 549 participants will be f…
Phase: NA • Sponsor: Kardium Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New mapping tech aims to sharpen heart ablation for AFib
Disease control TerminatedThis pilot study was designed to test a new, more targeted way to perform ablation for atrial fibrillation (AFib). Instead of burning a wide area around the pulmonary veins, doctors would use special mapping technology to precisely target the heart muscle sleeves causing the abno…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Sleep apnea device may keep heart rhythm in check
Disease control OngoingThis study looks at whether using a CPAP machine at night can reduce the chance of atrial fibrillation (an irregular heartbeat) returning in people who have both sleep apnea and a history of AF. Researchers will follow 91 adults for 12 months, tracking how often they use CPAP and…
Sponsor: Medical University of Sofia • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New balloon zaps away AFib without heat
Disease control OngoingThis study tests a new balloon catheter that uses pulsed electric fields instead of heat to treat atrial fibrillation (AFib), a common heart rhythm problem. About 35 adults with short-lasting AFib will receive the procedure. The goal is to see if the balloon safely and effectivel…
Phase: NA • Sponsor: The Third People's Hospital of Chengdu • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New study examines real-world use of heart ablation device for AFib patients
Disease control OngoingThis study tracks 344 adults with paroxysmal atrial fibrillation (a type of irregular heartbeat) who are having their first catheter ablation procedure using a specific device. The goal is to see how well the procedure works and how safe it is in everyday medical practice. Resear…
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Heart monitor after ablation may cut AF time
Disease control OngoingThis study tests whether using an implantable heart monitor (or a wearable patch) to detect atrial fibrillation early after catheter ablation can reduce the total time spent in AF. About 120 people with paroxysmal or persistent AF will be monitored for 15 months. The goal is to s…
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Freezing heart tissue: new balloon trial for AFib patients
Disease control OngoingThis trial tests a new device called the Synaptic Cryoablation System, which uses a balloon to freeze small areas of the heart and correct irregular heartbeats in people with paroxysmal atrial fibrillation. 128 participants will receive the treatment and be followed for 12 months…
Phase: NA • Sponsor: Synaptic Medical Corporation • Aim: Disease control
Last updated Jun 26, 2026 16:53 UTC
-
Smartwatch AI could spot hidden heart condition
Diagnosis OngoingThis study will test whether an artificial intelligence (AI) program can accurately detect atrial fibrillation (AF) using data from consumer smartwatches. Researchers will enroll 40 adults with AF who will wear a smartwatch while their heart rhythm is also monitored with standard…
Sponsor: Royal Brompton & Harefield NHS Foundation Trust • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
New algorithm aims to predict AF recurrence after ablation
Knowledge-focused OngoingThis study looks at whether a new computer algorithm can predict if atrial fibrillation (an irregular heartbeat) will come back after a common treatment called pulmonary vein isolation. Researchers will review medical records from 300 patients who had this procedure. The goal is …
Sponsor: CathVision ApS • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Heart device DiamondTemp under Real-World watch: will it deliver?
Knowledge-focused OngoingThis registry follows 545 people with arrhythmia who received a heart ablation using the DiamondTemp system. Researchers will track how many stay free of their heart rhythm problem and how many have serious side effects over 12 months. The goal is to see how well the device works…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New study aims to make heart ablation faster and safer
Knowledge-focused OngoingThis study looks at two methods for treating atrial fibrillation (an irregular heartbeat) using a special balloon catheter. The goal is to see if using a 3D mapping system (CARTO) makes the procedure faster and safer than using X-ray guidance alone. About 60 adults with paroxysma…
Phase: NA • Sponsor: Maria Cecilia Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Could cooling the esophagus make heart ablation safer?
Knowledge-focused OngoingThis study looks at whether actively cooling the esophagus during a common heart procedure (ablation for atrial fibrillation) helps improve outcomes and reduce side effects. Researchers will follow 312 adults with symptomatic atrial fibrillation who are already scheduled for abla…
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
New mapping technique for AF ablation never tested – study withdrawn
Knowledge-focused TerminatedThis study was designed to see if a new, ultra-sensitive mapping technique could better confirm that cryoballoon ablation successfully isolated the pulmonary veins in patients with paroxysmal atrial fibrillation. The trial was withdrawn before enrolling any participants, so no re…
Sponsor: BayCare Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC